Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Asian Pac J Cancer Prev ; 21(1): 99-106, 2020 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-31983171

RESUMO

BACKGROUND: The effect of Aloctin, a lectin purified from Aloe vera leaves, and aloe emodin an anthraquinone glycoside purified from the leaves of the same plant, on several cancer cell lines was investigated. METHODS: Aloctin was isolated from A. vera leaf skin by ammonium sulphate precipitation and CNBr-Sepharose 4B-ovalbumin affinity chromatography. Specific new ligands for Aloctin were detected as fetuin and avidin by hemagglutination inhibition tests. The cytotoxic effect of Aloctin and aloe emodin on various human cancer cell lines was tested using MTT assay. Imatinib was tested as standard positive control. The mechanism underlying was tested by the Annexin V-FITC/PI test, with flow cytometry. RESULTS: The most sensitive cells to Aloctin and aloe emodin treatment, were identified as AGS human gastric adenocarcinoma cells. The effect was concentration dependent. It was shown that this effect does not occur by apoptosis or necrosis. In Aloctin-imatinib combinations studies, Aloctin significantly increased the cytotoxic effect of imatinib in a dose-dependent manner. It is expected that the results of this study will reveal important findings for the future use of A. vera lectin as well as aloe emodin in cancer research and contribution to lectin biochemistry.
.


Assuntos
Aloe/química , Antraquinonas/farmacologia , Antineoplásicos/farmacologia , Lectinas/farmacologia , Extratos Vegetais/farmacologia , Neoplasias Gástricas/tratamento farmacológico , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Humanos , Folhas de Planta/química
2.
Balkan Med J ; 36(2): 96-105, 2019 02 28.
Artigo em Inglês | MEDLINE | ID: mdl-30396879

RESUMO

Background: Flavonoids are natural compounds with antioxidant, anticarcinogenic, and anti-inflammatory effects. Aims: To determine the cytotoxic effects of flavonoids and drug resistance related to P-gp on K562 human chronic myeloid leukemia cells. We also aimed to evaluate the therapeutic potential of imatinib and flavonoid combinations. Study Design: Cell culture study. Methods: In this study, K562 cells were treated with apigenin, luteolin, 5-desmethyl sinensetin and the anticancer drug imatinib mesylate. The effect of flavonoids on K562 cell proliferation was detected using the 3-(4,5-dimethylthiazolyl)2,5­diphenyl­tetrazolium bromide assay. Concentrations of apigenin, luteolin, and 5-desmethyl sinensetin ranging from 25 to 200 µM and of imatinib from 5 to 50 µM administered for 72 h were studied. Apoptosis/necrosis and P-gp activity were measured using flow cytometry. The combined effects of different concentrations of flavonoids with imatinib were evaluated according to combination index values calculated using CompuSyn software. Results: In our study, the IC50 values for apigenin, luteolin, and 5-desmethyl sinensetin were found to be 140 µM, 100 µM, and >200 µM, respectively. Luteolin (100 µM) had the highest cytotoxic activity of these flavonoids. These results were statistically significant (p<0.05). Among the flavonoids studied, the combination of luteolin and imatinib was the most effective and is therefore recommended for its cytotoxic activity in the K562 cell line. After 72 h of incubation at their respective IC50 concentrations, all flavonoids were associated with an apoptosis rate of approximately 50%. P-glycoprotein activity was increased in all groups. Combination treatment may provide better outcomes in terms of cytotoxicity and thus reduce the dosages of imatinib used. Conclusion: The combination of some flavonoids and imatinib mesylate may increase the cytotoxic effect; However, the antagonistic effect should be considered in combined use on k562 cells.


Assuntos
Flavonoides/efeitos adversos , Mesilato de Imatinib/efeitos adversos , Células K562/efeitos dos fármacos , Leucemia Mieloide/genética , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Citotoxinas/efeitos adversos , Citotoxinas/uso terapêutico , Análise de Dados , Flavonoides/uso terapêutico , Humanos , Mesilato de Imatinib/uso terapêutico
3.
Oxid Med Cell Longev ; 2(2): 99-106, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20357932

RESUMO

In order to demonstrate whether the known biological effects of Aloe vera (L.) Burm. fil. could correlate with the antioxidant activity of the plant, the antioxidant activity of the aqueous leaf extract was investigated. The present study demonstrated that the aqueous extract from A. vera leaves contained naturally occuring antioxidant components, including total phenols, flavonoids, ascorbic acid, beta-carotene and alpha-tocopherol. The extract exhibited inhibitory capacity against Fe(3+)/ascorbic acid induced phosphatidylcholine liposome oxidation, scavenged stable DPPH(*), ABTS(*+) and superoxide anion radicals, and acted as reductant. In contrast, the leaf inner gel did not show any antioxidant activity. It was concluded that the known beneficial effects of Aloe vera could be attributed to its antioxidant activity and could be related to the presence of phenolic compounds and antioxidant vitamins.


Assuntos
Aloe/química , Antioxidantes/farmacologia , Extratos Vegetais/farmacologia , Ácido Ascórbico/uso terapêutico , Benzotiazóis/química , Compostos de Bifenilo/química , Flavonoides/uso terapêutico , Sequestradores de Radicais Livres/uso terapêutico , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Doenças Neurodegenerativas/tratamento farmacológico , Fenóis/farmacologia , Picratos/química , Extratos Vegetais/uso terapêutico , Folhas de Planta/química , Ácidos Sulfônicos/química , Superóxidos/química , beta Caroteno/uso terapêutico , beta-Tocoferol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA